Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration

2020173 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov Identifier: NCT03038880.

Good health and well-being

Published in: JAMA Ophthalmology

Volume 138, Issue 9, pp. 964-964

Field-Weighted Citation Impact: 16.19